ArticleThe oncologist2019

Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.

Jin G Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.